Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
11 2020
Historique:
received: 09 09 2020
accepted: 10 09 2020
pubmed: 6 10 2020
medline: 27 11 2020
entrez: 5 10 2020
Statut: ppublish

Résumé

Covid-19 can involve multiple organs including the nervous system. We sought to characterize the neurologic manifestations, their risk factors, and associated outcomes in hospitalized patients with Covid-19. We examined neurologic manifestations in 509 consecutive patients admitted with confirmed Covid-19 within a hospital network in Chicago, Illinois. We compared the severity of Covid-19 and outcomes in patients with and without neurologic manifestations. We also identified independent predictors of any neurologic manifestations, encephalopathy, and functional outcome using binary logistic regression. Neurologic manifestations were present at Covid-19 onset in 215 (42.2%), at hospitalization in 319 (62.7%), and at any time during the disease course in 419 patients (82.3%). The most frequent neurologic manifestations were myalgias (44.8%), headaches (37.7%), encephalopathy (31.8%), dizziness (29.7%), dysgeusia (15.9%), and anosmia (11.4%). Strokes, movement disorders, motor and sensory deficits, ataxia, and seizures were uncommon (0.2 to 1.4% of patients each). Severe respiratory disease requiring mechanical ventilation occurred in 134 patients (26.3%). Independent risk factors for developing any neurologic manifestation were severe Covid-19 (OR 4.02; 95% CI 2.04-8.89; P < 0.001) and younger age (OR 0.982; 95% CI 0.968-0.996; P = 0.014). Of all patients, 362 (71.1%) had a favorable functional outcome at discharge (modified Rankin Scale 0-2). However, encephalopathy was independently associated with worse functional outcome (OR 0.22; 95% CI 0.11-0.42; P < 0.001) and higher mortality within 30 days of hospitalization (35 [21.7%] vs. 11 [3.2%] patients; P < 0.001). Neurologic manifestations occur in most hospitalized Covid-19 patients. Encephalopathy was associated with increased morbidity and mortality, independent of respiratory disease severity.

Identifiants

pubmed: 33016619
doi: 10.1002/acn3.51210
pmc: PMC7664279
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2221-2230

Subventions

Organisme : NINDS NIH HHS
ID : L30 NS098427
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Crit Care Med. 2018 Sep;46(9):e825-e873
pubmed: 30113379
Clin Infect Dis. 2020 Jul 28;71(15):713-720
pubmed: 32129843
JAMA Intern Med. 2020 Jul 15;:
pubmed: 32667668
Lancet Psychiatry. 2020 Oct;7(10):875-882
pubmed: 32593341
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Front Neurol. 2020 Jul 07;11:781
pubmed: 32733373
J Emerg Med. 2018 Jun;54(6):785-792
pubmed: 29523426
Ann Intern Med. 1990 Dec 15;113(12):941-8
pubmed: 2240918
J Neurovirol. 2020 Apr;26(2):143-148
pubmed: 32447630
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Neurol. 2020 Jun;267(6):1573-1576
pubmed: 32436101
Neurology. 2020 May 12;94(19):809-810
pubmed: 32229625
JAMA. 2010 Jul 28;304(4):443-51
pubmed: 20664045
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1331-7
pubmed: 24102675
Crit Care. 2017 Mar 21;21(1):65
pubmed: 28320461
J Neurol. 2006 Jul;253(7):833-45
pubmed: 16715200
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Neurology. 2020 Aug 25;95(8):e1060-e1070
pubmed: 32482845
Ann Neurol. 2020 Jul;88(1):1-11
pubmed: 32506549
N Engl J Med. 2014 Jan 30;370(5):444-54
pubmed: 24476433
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
Med Hypotheses. 2020 Jun 27;144:110055
pubmed: 32758891
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Nat Rev Neurol. 2012 Oct;8(10):557-66
pubmed: 22986430

Auteurs

Eric M Liotta (EM)

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Ayush Batra (A)

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Jeffrey R Clark (JR)

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Nathan A Shlobin (NA)

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Steven C Hoffman (SC)

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Zachary S Orban (ZS)

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Igor J Koralnik (IJ)

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH